Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept-Reference-Cited by-同舟云学术

Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept

Published:2018-02-12 Issue:6 Volume:9 Page:121-123
ISSN:2040-6223
Container-title:Therapeutic Advances in Chronic Disease
language:en
Short-container-title:Therapeutic Advances in Chronic Disease

Author:

Rendina Maria¹,Castellaneta Nicola Maurizio¹,Losurdo Giuseppe¹,Castellaneta Antonino¹,Cazzolla Annamaria¹,Chialà Claudia¹,D’Errico Francesca¹,Di Leo Alfredo²

Affiliation:

1. Section of Gastroenterology, Department of Emergency and Organ Transplantation, University Hospital, Bari, Italy

2. Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Piazza Giulio Cesare, Bari, 70124, Italy

Publisher

SAGE Publications

Subject

Medicine (miscellaneous)

Link

http://journals.sagepub.com/doi/pdf/10.1177/2040622318755651

Reference11 articles.

1. Primary biliary cirrhosis induced by interferon-α therapy for hepatitis C virus infection

2. EASL Recommendations on Treatment of Hepatitis C 2016

3. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

4. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome

5. Antimitochondrial antibody -M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary biliary cholangitis development after hepatitis C virus eradication with direct acting antivirals: a case report and review of the literature;EUR REV MED PHARMACO;2020

2. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN);Digestive and Liver Disease;2018-11

3. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN);Internal and Emergency Medicine;2018-09-25

4. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN);Journal of Nephrology;2018-09-25

5. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN);Infection;2018-09-25